Brookstone Capital Management increased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 10.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,907 shares of the biopharmaceutical company’s stock after acquiring an additional 3,439 shares during the period. […]
Juncture Wealth Strategies LLC lessened its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 39,474 shares of the biopharmaceutical company’s stock after selling 908 shares during the quarter. Juncture Wealth Strategies LLC’s holdings in Catalyst […]
Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 47.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,300 shares of the biopharmaceutical company’s stock after purchasing an additional 26,600 shares during the quarter. […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Zacks Research lowered their Q3 2023 earnings estimates for Catalyst Pharmaceuticals in a report issued on Wednesday, August 23rd. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will earn ($0.21) per share for the quarter, down from their previous estimate of $0.27. The consensus […]
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.